Treace Medical Concepts, Inc. TMCI Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s debt issuance cost amortization?
- Treace Medical Concepts, Inc. (TMCI) reported debt issuance cost amortization of $262K in Q1 2026.
- How has Treace Medical Concepts, Inc.'s debt issuance cost amortization changed year-over-year?
- Treace Medical Concepts, Inc.'s debt issuance cost amortization increased by 254.1% year-over-year, from $74K to $262K.
- What is the long-term trend for Treace Medical Concepts, Inc.'s debt issuance cost amortization?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s debt issuance cost amortization has grown at a 13.5% compound annual growth rate (CAGR), from $176K to $292K.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).